Exact Mass: 393.1496

Exact Mass Matches: 393.1496

Found 72 metabolites which its exact mass value is equals to given mass value 393.1496, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

gamma-Glutamylfelinylglycine

2-Amino-5-[[1-(carboxymethylamino)-3-(4-hydroxy-2-methylbutan-2-yl)sulfanyl-1-oxopropan-2-yl]amino]-5-oxopentanoic acid

C15H27N3O7S (393.157)

1-[5-(2-Cyclopropyl-5,7-dimethylimidazo[4,5-b]pyridin-3-ylmethyl)thiophen-2-yl]cyclopent-3-ene carboxylic acid

1-[5-({2-cyclopropyl-5,7-dimethyl-3H-imidazo[4,5-b]pyridin-3-yl}methyl)thiophen-2-yl]cyclopent-3-ene-1-carboxylic acid

C22H23N3O2S (393.1511)

Asn Ser Ser Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxypropanamido]-3-hydroxypropanamido]-3-hydroxypropanoic acid

C13H23N5O9 (393.1496)

Tyr Asp Pro

C18H23N3O7 (393.1536)

Ser Asn Ser Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-carbamoylpropanamido]-3-hydroxypropanamido]-3-hydroxypropanoic acid

C13H23N5O9 (393.1496)

Ser Ser Asn Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxypropanamido]-3-carbamoylpropanamido]-3-hydroxypropanoic acid

C13H23N5O9 (393.1496)

Ser Ser Ser Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxypropanamido]-3-hydroxypropanamido]-3-carbamoylpropanoic acid

C13H23N5O9 (393.1496)

N-Desmethyltrifluoperazine

C20H22F3N3S (393.1486)

Ent-cinacalcet hydrochloride

C22H23ClF3N (393.1471)

7-FLUORO-3,4-DIHYDRO-4-[(5-ISOQUINOLINYLOXY)ACETYL]-1,3,3-TRIMETHYL-2(1H)-QUINOXALINONE

C22H20FN3O3 (393.1489)

2,6-BIS((3AS,8AR)-8,8A-DIHYDRO-3AH-INDENO[1,2-D]OXAZOL-2-YL)PYRIDINE

C25H19N3O2 (393.1477)

Cinacalcet hydrochloride

C22H23ClF3N (393.1471)

D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D057966 - Calcimimetic Agents C78275 - Agent Affecting Blood or Body Fluid > C2136 - Malignancy-Associated Hypercalcemia Inhibitor D000077264 - Calcium-Regulating Hormones and Agents

5-(6-(BENZYLOXY)NAPHTHALEN-2-YL)-2,2-DIMETHYL-5-NITRO-1,3-DIOXANE

C23H23NO5 (393.1576)

4-Cyanophenyl 4-(6-acryloyloxyhexyloxy)benzoate

C23H23NO5 (393.1576)

methyl 2-[(3-cyanobenzoyl)amino]-3-(3-methoxypropyl)imidazo[4,5-b]pyridine-6-carboxylate

C20H19N5O4 (393.1437)

Befiradol

C20H22ClF2N3O (393.1419)

Befiradol (NLX-112) is a selective 5-HT1A receptor agonist.

BOC-THIONOLEU-1-(6-NITRO)BENZOTRIAZOLIDE

C17H23N5O4S (393.1471)

7-[2-[[(1S,2S)-1-hydroxy-1-phenylpropan-2-yl]amino]ethyl]-1,3-dimethylpurine-2,6-dione,hydrochloride

C18H24ClN5O3 (393.1568)

2,6-BIS((3AR,8AS)-8,8A-DIHYDRO-3AH-INDENO[1,2-D]OXAZOL-2-YL)PYRIDINE

C25H19N3O2 (393.1477)

(S)-Cinacalcet hydrochloride

C22H23ClF3N (393.1471)

C22H22F3N.HCl

C22H22F3N.HCl (393.1471)

Dansyltryptamine

C22H23N3O2S (393.1511)

MOLYBDENUM (V) ISOPROPOXIDE

C15H35MoO5 (393.1538)

5-Ethoxychelerthrine

C23H23NO5 (393.1576)

4-(3-(4-(1-methyl-1H-pyrazol-5-yl)phenylthio)phenyl)-tetrahydro-2H-pyran-4-carboxamide

C22H23N3O2S (393.1511)

PF-4191834 (PF-04191834) is an orally active, noniron chelating, and non-redox inhibitor of the 5-Lipoxygenase (5-LOX) (IC50=229 nM), displays ~300-fold selectivity for 5-LOX over 12-LOX and 15-LOX, shows no activity toward the cyclooxygenase enzymes, and is effective in inflammation and pain[1].

2-fluoro-N-[4-[4-[2-furanyl(oxo)methyl]-1-piperazinyl]phenyl]benzamide

C22H20FN3O3 (393.1489)

1-(3,4-dihydro-2H-quinolin-1-yl)-2-[[1-(4-ethoxyphenyl)-2-imidazolyl]thio]ethanone

C22H23N3O2S (393.1511)

gamma-Glutamylfelinylglycine

C15H27N3O7S (393.157)

3-[(2E,4E,6E)-6,8-dimethyldeca-2,4,6-trienoyl]-1-hydroxy-5-(4-oxidophenyl)-2-oxopyridin-4-olate

C23H23NO5-2 (393.1576)

1-[4-(4-Phenylmethoxyphenyl)-2-thiazolyl]-4-piperidinecarboxamide

C22H23N3O2S (393.1511)

N-(3-imidazol-1-ylpropyl)-2-[(4-nitrobenzoyl)amino]benzamide

C20H19N5O4 (393.1437)

N-{(E)-[2,4,6-trioxo-1-(2,4,6-trimethylphenyl)tetrahydropyrimidin-5(2H)-ylidene]methyl}pyridine-4-carbohydrazide

C20H19N5O4 (393.1437)

2,5-Dimethyl-3-furancarboxylic acid [2-(2-ethoxyanilino)-2-oxo-1-phenylethyl] ester

C23H23NO5 (393.1576)

[(1S,2aR,8bR)-1-(hydroxymethyl)-2-(4-oxazolylmethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-4-yl]-(3-fluorophenyl)methanone

C22H20FN3O3 (393.1489)

[(1R,2aS,8bS)-1-(hydroxymethyl)-2-(4-oxazolylmethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-4-yl]-(3-fluorophenyl)methanone

C22H20FN3O3 (393.1489)

Asp-Pro-Tyr

C18H23N3O7 (393.1536)

Pro-Asp-Tyr

C18H23N3O7 (393.1536)

Tyr-Asp-Pro

C18H23N3O7 (393.1536)

Asp-Tyr-Pro

C18H23N3O7 (393.1536)

Pro-Tyr-Asp

C18H23N3O7 (393.1536)

Tyr-Pro-Asp

C18H23N3O7 (393.1536)

Cyclohexyl 2-methyl-4-thiophen-2-yl-3,4-dihydropyrimido[1,2-a]benzimidazole-3-carboxylate

C22H23N3O2S (393.1511)

(2,5-Dioxopyrrolidin-1-yl) 4-(3,6-diaminoacridin-10-ium-10-yl)butanoate

C21H21N4O4+ (393.1563)

LPC 8:3;O

C16H28NO8P (393.1552)

Agomelatine (L(+)-Tartaric acid)

C19H23NO8 (393.1424)

Agomelatine L(+)-Tartaric acid (S-20098 L(+)-Tartaric acid) is a specific agonist of MT1 and MT2 receptors with Kis of 0.1, 0.06, 0.12, and 0.27 nM for CHO-hMT1, HEK-hMT1, CHO-hMT2, and HEK-hMT2, respectively[1]. Agomelatine L(+)-Tartaric acid is a selective 5-HT2C receptor antagonist with pKis of 6.4 and 6.2 at native (porcine) and cloned, human 5-HT2C receptors, respectively[2].

CJ-13,610

C22H23N3O2S (393.1511)

CJ-13,610, a nonredox-type 5-LO inhibitor, dose dependently suppresses 5-LO product formation in ionophore A23187-stimulated PMNL in the absence of exogenous AA with an IC50 of about 70 nM[1]. PMNL: polymorphonuclear leukocytes; AA: arachidonic acid